Who owns Oncolytics Biotech Inc?
- Ticker: ONCY
- CUSIP Number: 682310875
Tip: Access positions for across all investors
Analyze quarterly positions in Oncolytics Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Oncolytics Biotech stock
Who bought or sold Oncolytics Biotech Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
International Assets Investment Management | 202k | $214k | 1% | Mar 2024 |
|
Millennium Management | 128k | $173k | -40% | Dec 2023 |
|
Citadel Advisors | 114k | $154k | 100% | Dec 2023 |
|
Advisor Resource Council | 100k | $135k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 56k | $75k | 100% | Dec 2023 |
|
Royal Bank of Canada | 55k | $74k | -1% | Dec 2023 |
|
Long Focus Capital Management | 40k | $54k | 0% | Dec 2023 |
|
Bank Of Montreal | 38k | $51k | 15% | Dec 2023 |
|
Ausdal Financial Partners | 26k | $28k | -13% | Mar 2024 |
|
Brave Asset Management | 25k | $34k | 0% | Dec 2023 |
|
Two Sigma Securities | 23k | $32k | 100% | Dec 2023 |
|
Newman Dignan & Sheerar | 22k | $30k | 100% | Dec 2023 |
|
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 15k | $20k | 100% | Dec 2023 |
|
Banque Cantonale Vaudoise | 12k | $13k | 0% | Mar 2024 |
|
Headinvest | 12k | $16k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 12k | $16k | 100% | Dec 2023 |
|
Kingsview Wealth Management | 11k | $15k | 100% | Dec 2023 |
|
Scotia Capital | 11k | $14k | 100% | Dec 2023 |
|
Advisor Group Holdings | 9.2k | $12k | -5% | Dec 2023 |
|
Bank of America Corporation | 6.1k | $8.2k | 29% | Dec 2023 |
|
Cedar Mountain Advisors | 5.7k | $6.0k | 0% | Mar 2024 |
|
UBS Group | 4.7k | $4.7k | -39% | Dec 2023 |
|
Wells Fargo & Company | 4.7k | $6.3k | -25% | Dec 2023 |
|
National Bank Of Canada /fi/ | 3.7k | $4.9k | 1% | Dec 2023 |
|
CWM | 2.3k | $2.0k | 0% | Mar 2024 |
|
Barclays | 1.2k | $2.0k | 50% | Dec 2023 |
|
TD Waterhouse Canada | 557.00 | $970.015500 | 0% | Dec 2023 |
|
Planning Capital Management Corp | 215.00 | $291.002500 | 100% | Dec 2023 |
|
JNBA Financial Advisors | 210.00 | $284.004000 | 0% | Dec 2023 |
|
Hobbs Group Advisors | 105.00 | $142.002000 | 100% | Dec 2023 |
|
Advisory Services Network | 100.00 | $135.000000 | 100% | Dec 2023 |
|
Cypress Capital Management | 100.00 | $135.000000 | 0% | Dec 2023 |
|
Wolff Wiese Magana | 31.00 | $32.999500 | 0% | Mar 2024 |
|
Who sold out of Oncolytics Biotech?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Dimensional Fund Advisors | Sep 2023 | 34k | $73k |
Bnp Paribas Arbitrage, Snc | Sep 2023 | 22k | $49k |
Squarepoint Ops | Sep 2023 | 12k | $26k |
IFP Advisors | Sep 2023 | 2.0k | $4.4k |
Pnc Financial Services | Sep 2023 | 1.2k | $2.6k |